Profile: BioMedica, Inc.
BioHealth Investor Company Directory Profile
BioMedica, Inc.
11622 El Camino Real #100
San Diego, CA 92130
Tel 858 677 6500
Fax 858.677.6505
BioMedica Inc, located in San Diego, California, is a wholly owned subsidiary of Oxford BioMedica plc (LSE: OXB), a UK based biotechnology company specializing in the development of novel gene-based therapeutics for the treatment of cancer, neurodegenerative diseases and other disorders with major unmet clinical needs.
BioMedica Inc is focused primarily on business development activities in North America and Asia and on management of the Company’s intellectual property.
Oxford BioMedica’s development pipeline includes two novel anti-cancer products, TroVax® and MetXia®, in clinical trials and gene therapy treatments in advanced preclinical studies for retinopathy, RetinoStat®, and for Parkinson’s disease, ProSavin®.
This is a BioHealth Investor company profile. Promote your company, learn how...
____________________
BioMedica, Inc.11622 El Camino Real #100
San Diego, CA 92130
Tel 858 677 6500
Fax 858.677.6505
BioMedica Inc, located in San Diego, California, is a wholly owned subsidiary of Oxford BioMedica plc (LSE: OXB), a UK based biotechnology company specializing in the development of novel gene-based therapeutics for the treatment of cancer, neurodegenerative diseases and other disorders with major unmet clinical needs.
BioMedica Inc is focused primarily on business development activities in North America and Asia and on management of the Company’s intellectual property.
Oxford BioMedica’s development pipeline includes two novel anti-cancer products, TroVax® and MetXia®, in clinical trials and gene therapy treatments in advanced preclinical studies for retinopathy, RetinoStat®, and for Parkinson’s disease, ProSavin®.
This is a BioHealth Investor company profile. Promote your company, learn how...
____________________
posted by Nico at
12:42 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home